Related Experiment Video
Updated: Aug 2, 2026
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Photoradiation therapy of cutaneous angiosarcomas in mice
Abstract:
Cutaneous angiosarcoma is a relatively rare but devastating malignant vascular tumor. It has a high incidence of recurrence following conventional therapeutic modalities applied either singly or in combination. The increased vascularity of cutaneous angiosarcomas, facilitating selective uptake and retention of a photosensitizing agent, such as hematoporphyrin derivative (HPD), suggests that these tumors would respond well to photoradiation therapy. To study the feasibility of this treatment modality, transplantable hemangiosarcomas were implanted in B6C3F1 female mice. Within 2.5 to 3.5 hours after intraperitoneal administration of HPD, fluorescence was recorded in the tumor as compared with surrounding normal skin. When these photosensitized tumors were exposed to 70 J/cm2 of laser energy from an argon-pumped dye laser at 630 nm, the tumors showed marked necrosis within 24 hours. In another series, the tumors were initially photosensitized with HPD for 3 hours and then treated with laser energy ranging from 0 to 96 J/cm2. A dual labeling procedure demonstrated a dose-related decrease in DNA synthesis rate in tumors that were exposed to 0 to 30 J/cm2 at 24 hours after treatment. Furthermore, tumor tissue exposed to laser energy in excess of 30 J/cm2 showed no significant cellular DNA synthesis. These data, supported by histologic evidence of tissue destruction, suggest that photoradiation therapy has a great potential as a therapeutic modality for cutaneous angiosarcomas.
Insights
Photoradiation therapy using hematoporphyrin derivative (HPD) shows promise for treating cutaneous angiosarcomas. This method effectively caused tumor necrosis and reduced DNA synthesis in preclinical models.
Area of Science:
- Oncology
- Dermatology
- Biomedical Engineering
Background:
- Cutaneous angiosarcoma is a rare, aggressive vascular tumor with high recurrence rates.
- Conventional treatments often fail to prevent tumor regrowth.
- The vascular nature of these tumors suggests potential for targeted therapies like photoradiation.
Purpose of the Study:
- To evaluate the feasibility and efficacy of photoradiation therapy (PRT) for cutaneous angiosarcomas.
- To assess the impact of HPD-mediated PRT on tumor necrosis and DNA synthesis in a preclinical model.
Main Methods:
- Transplantable hemangiosarcomas were implanted in female B6C3F1 mice.
- Mice received intraperitoneal administration of hematoporphyrin derivative (HPD).
- Photosensitized tumors were exposed to specific doses of 630 nm laser energy.
Main Results:
- HPD administration resulted in selective tumor fluorescence.
- Laser treatment induced marked tumor necrosis within 24 hours.
- A dose-dependent decrease in tumor DNA synthesis was observed, with significant inhibition above 30 J/cm2.
Conclusions:
- Photoradiation therapy with HPD demonstrates significant potential for treating cutaneous angiosarcomas.
- The therapy effectively induced tumor destruction and inhibited cellular proliferation.
- Further investigation into HPD-mediated PRT as a therapeutic option is warranted.
